Skip to main content
logo
Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
7.85
+0.74 (10.41%)
At close: Aug 14, 2026, 4:00 PM EDT
7.58
-0.27 (-3.44%)
After-hours: Aug 14, 2026, 7:48 PM EDT

Aspire Biopharma Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
10148998370
Market Cap Growth
-48.55%-84.12%-8.80%-73.55%-
Enterprise Value
-22190--
Last Close Price
7.85158.2813800.0113068.0112360.01

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
104.112285.75---
PB Ratio
0.86-2.22-57.97-200.68-2874.02
P/OCF Ratio
---8791.81-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
-3362.25---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
--0.81-0.82-0.74-0.22
Net Debt / Equity Ratio
-1.03-0.65-0.82-0.72-0.22
Asset Turnover
0.010.01---
Quick Ratio
7.220.130.000.020
Current Ratio
7.990.170.090.090.15
Return on Assets (ROA)
60.58%-446.87%-779.55%-652.34%-
Return on Capital Employed (ROCE)
59.40%83.10%78.60%73.50%463.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-108.67%-172.69%-1.47%-0.37%-0.16%
Buyback Yield / Dilution
-1015.92%-116.69%100.00%--
SEC Filings: 10-K · 10-Q